S. Wolf et al., HEMODILUTION THERAPY IN CENTRAL RETINAL VEIN OCCLUSION - ONE-YEAR RESULTS OF A PROSPECTIVE RANDOMIZED STUDY, Graefe's archive for clinical and experimental ophthalmology, 232(1), 1994, pp. 33-39
Systemic hemorheologic abnormalities may play a part in the pathogenes
is of central retinal vein occlusions. A statistically significant ele
vation of plasma viscosity was found in patients with acute central re
tinal vein occlusion compared with control patients. Local retinal blo
od flow parameters including arteriovenous passage time and mean arter
ial dye bolus velocity were significantly altered in the central retin
al vein occlusion patients compared with age-matched controls at basel
ine examination. We performed a randomized, prospective, single-blind
clinical investigation to determine the effect of hemorheological mani
pulation on the clinical course and retinal blood flow of eyes with ce
ntral vein occlusion. Hemodilution included plasma expansion with hydr
oxyethyl-starch, withdrawal of whole blood if the hematocrit was above
42%, and rheologic manipulation with parenteral pentoxifylline. We fo
und a statistically significant improvement in visual acuity at 1 year
post-treatment for the treated group compared with the control group
(increase of visual acuity of 1.5 lines vs decrease of 1.5 lines). The
retinal blood flow parameters were markedly improved soon after the i
nstitution of therapy, and this may have contributed to the improvemen
t in visual acuity in the treated group. There was no statistically si
gnificant difference between the two groups in the progression to isch
emic central vein occlusion.